Cooper EBIT 2010-2024 | COO
Cooper annual and quarterly EBIT history from 2010 to 2024. EBIT can be defined as earnings before interest and taxes.
- Cooper EBIT for the quarter ending July 31, 2024 was $0.193B, a 26.98% increase year-over-year.
- Cooper EBIT for the twelve months ending July 31, 2024 was $643M, a 28.37% increase year-over-year.
- Cooper 2023 annual EBIT was $0.533B, a 5.02% increase from 2022.
- Cooper 2022 annual EBIT was $0.508B, a 0.36% increase from 2021.
- Cooper 2021 annual EBIT was $0.506B, a 62.22% increase from 2020.
Cooper Annual EBIT (Millions of US $) |
2023 |
$533 |
2022 |
$508 |
2021 |
$506 |
2020 |
$312 |
2019 |
$547 |
2018 |
$403 |
2017 |
$429 |
2016 |
$324 |
2015 |
$237 |
2014 |
$306 |
2013 |
$306 |
2012 |
$283 |
2011 |
$228 |
2010 |
$190 |
2009 |
$150 |
Cooper Quarterly EBIT (Millions of US $) |
2024-07-31 |
$193 |
2024-04-30 |
$162 |
2024-01-31 |
$153 |
2023-10-31 |
$136 |
2023-07-31 |
$152 |
2023-04-30 |
$96 |
2023-01-31 |
$150 |
2022-10-31 |
$104 |
2022-07-31 |
$141 |
2022-04-30 |
$133 |
2022-01-31 |
$131 |
2021-10-31 |
$129 |
2021-07-31 |
$101 |
2021-04-30 |
$143 |
2021-01-31 |
$133 |
2020-10-31 |
$100 |
2020-07-31 |
$72 |
2020-04-30 |
$29 |
2020-01-31 |
$111 |
2019-10-31 |
$147 |
2019-07-31 |
$142 |
2019-04-30 |
$147 |
2019-01-31 |
$111 |
2018-10-31 |
$123 |
2018-07-31 |
$116 |
2018-04-30 |
$75 |
2018-01-31 |
$90 |
2017-10-31 |
$109 |
2017-07-31 |
$113 |
2017-04-30 |
$117 |
2017-01-31 |
$91 |
2016-10-31 |
$74 |
2016-07-31 |
$103 |
2016-04-30 |
$90 |
2016-01-31 |
$57 |
2015-10-31 |
$42 |
2015-07-31 |
$50 |
2015-04-30 |
$71 |
2015-01-31 |
$73 |
2014-10-31 |
$39 |
2014-07-31 |
$97 |
2014-04-30 |
$89 |
2014-01-31 |
$82 |
2013-10-31 |
$62 |
2013-07-31 |
$94 |
2013-04-30 |
$81 |
2013-01-31 |
$69 |
2012-10-31 |
$79 |
2012-07-31 |
$77 |
2012-04-30 |
$65 |
2012-01-31 |
$62 |
2011-10-31 |
$67 |
2011-07-31 |
$52 |
2011-04-30 |
$60 |
2011-01-31 |
$49 |
2010-10-31 |
$63 |
2010-07-31 |
$51 |
2010-04-30 |
$39 |
2010-01-31 |
$37 |
2009-10-31 |
$42 |
2009-07-31 |
$34 |
2009-04-30 |
$41 |
2009-01-31 |
$33 |
Sector |
Industry |
Market Cap |
Revenue |
Medical |
Medical & Dental Supplies |
$19.726B |
$3.593B |
The Cooper Companies Inc, is a specialty medical device company operating on a global basis. Cooper has two business segments- CooperVision and CooperSurgical. CooperVision manufactures and sells a wide range of contact lenses. CooperVision develops manufactures and markets a broad range of single-use, two-week and monthly contact lenses, featuring advanced materials and optics. The company's products are primarily designed for solving vision challenges like astigmatism, presbyopia and ocular dryness.?CooperSurgical sells a variety of medical devices and surgical instruments that are primarily utilized by gynecologists and obstetricians.
|